openPR Logo
Press release

Blepharitis Treatment Market - Size, Share, Trends, Outlook, and Opportunity Analysis, 2018-2026

07-11-2018 02:26 PM CET | Health & Medicine

Press release from: CMI - Pharmaceutical Industry

Blepharitis Treatment Market - Size, Share, Trends, Outlook,

Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of skin around the eyes, crusted eyelashes after waking up, more frequent blinking, abnormal growth of eyelashes, and stinging sensation in the eyes. Blepharitis causes seborrheic dermatitis, which is dandruff of the eyebrows and scalp, bacterial infection, clogged oil glands, malfunctioning of oil glands, rosacea. It also causes allergic reactions to eye medications, contact lens solutions or eye make-up and eyelash lice or mites.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1761

Blepharitis Treatment Market Drivers:-

The blepharitis treatment market is expected to witness significant grow due to growing prevalence of ophthalmic disorders among the geriatric population. According to a survey conducted by American Academy of Ophthalmology in 2014, blepharitis usually affects people above the age of 50 years. It also states that blepharitis is observed in 37% male ophthalmic patients and 47% in female ophthalmic patients. Blepharitis market is also expected to grow due to increasing number of drugs in the pipeline. For instance, ISV-305 sponsored by InSite Vision is in phase 3 clinical trials, ISV-305 treats patients with early symptoms of blepharitis. Furthermore, new product launches and mergers and acquisitions over the recent past also contributes to market growth. For instance, in 2015, BlephEx, a Franklin-based company launched Rysurg. It is used to clean eyelids and also maintains hygiene. According to a study conducted by American Academy of Ophthalmology in 2015 around 50% of ophthalmic patients suffer from symptoms of blepharitis and dry eyes. Constant use of this device helps prevent recurrence of blephairis and the treatment is pain-free. In 2013, Shire Plc, purchased Californian Ophthalmic Company SARcode Bioscience to add new drug lifitegrast to Shire’s specialist drug portfolio. Lifitegrast was approved by the FDA for the treatment of signs and symptoms of dry eye and blepharitis in 2016.

Factors hampering growth of blepharitis market include lack of awareness regarding treatment of this chronic condition and high cost of the medication required to treat blepharitis.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1761

Blepharitis Treatment Market Regional Analysis:-

North America Blepharitis treatment market is expected to hold dominant position due to increasing geriatric population, launch of new products, and increasing number of ophthalmic patients in the region. According to a survey conducted in the U.S., by Population Reference Bureau in 2016, states that the aging population increased by 24% as compared to 15% in 2014. Europe is expected to witness rapid growth due to new product launches of blepharitis drugs in the region. For instance, in 2017, Scope Ophthalmic launched Moist Heat Mask, a device that helps in the treatment of blepharitis by loosening the oil present in Meibomian glands and allowing it to flow more freely. It helps to soften eye lash debris, prevent the evaporation of natural tear film, restores moisture to the eye and also the surrounding area, as well as improves tear film lipid quality. In 2015, MiBo Medical Group, a U.K.-based company, launched MibO Thermoflo. This device helps in the treatment of blepharitis and dry eyes and is required to be gently massaged on the margins of the eyelids for a minimum of 12 minutes. In 2015, MiBo Medical Group launched Lid Pro, a device that is used to treat anterior Blepharitis. The region of Asia Pacific is expected to witness significant growth due to increasing prevalence of blepharitis. According to a study conducted by Journal of Clinical and Experimental Ophthalmology in 2016, signs and symptoms of blepharitis increased by 32% among the geriatric population as compared to 2014.

Request TOC of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1761

Blepharitis Treatment Market Key Players:-

Key players operating in the Blepharitis treatment market include Scope Ophthalmic Ltd, NovaBay Pharmaceuticals Inc, Thea Pharmaceuticals Ltd, Perrigo Laboratories, InSite Vision Incorporated, Merck & Co, and Novartis AG

Blepharitis Treatment Market Taxonomy:-

The global Blepharitis treatment market is segmented based on disease type, treatment type, distribution channel, and region.

By Disease Type:- Posterior Blepharitis, Anterior Blepharitis, Mixed Blepharitis,.

By Treatment Type:- Antibiotic Therapy, Topical Corticosteroids, Topical Antibodies, Oral Antibodies, Ointments, Eye Cleansers, Others,.

By Distribution Channel:- Hospital Pharmacies, Retail Pharmacies, Online Pharmacies,.

By Region:- North America, Europe, Latin America, Asia-Pacific, Middle East, Africa,.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blepharitis Treatment Market - Size, Share, Trends, Outlook, and Opportunity Analysis, 2018-2026 here

News-ID: 1120732 • Views:

More Releases from CMI - Pharmaceutical Industry

Empty Capsules Market to Surpass US$ 2.79 Billion Threshold by 2025 Globally | Leading Players ACG Associated Capsules Pvt. Ltd., Capsugel, Inc., CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc., JC Biological Technology Co., Patheon, Inc., Roxlor L
Empty Capsules Market to Surpass US$ 2.79 Billion Threshold by 2025 Globally | L …
The Global Empty Capsules Market by Product Type (Gelatin Capsules (Porcine, Bovine, and Bone Meal), Non-Gelatin Capsules (HPMC and Pullulan)), By Application (Antibiotics, Vitamins, Anti-Inflammatory, Anti-Anemic and Others), By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 1.55 billion in 2016 and is projected to exhibit a CAGR of 7.7% over the
Significant Number of Pipeline Drugs to Surge Hereditary Angioedema Market beyond US$ 3.4 Billion by 2025 | Top Players CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceutic
Significant Number of Pipeline Drugs to Surge Hereditary Angioedema Market beyon …
The Global Hereditary Angioedema Market, by Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), by Route of Administration (Subcutaneous, Intravenous, and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 1,563.7 million in 2016 and is projected to exhibit a CAGR of 9.1% over the
Ulcerative Colitis Market to Incur Fortitude Growth During 2018-2026 by Global Top Players - AbbVie Inc., Hospira, Celltrion Healthcare, Johnson and Johnson, F. Hoffmann-La Roche AG, Warner Chilcott, Janssen Pharmaceuticals Inc. and Takeda Pharmaceuticals
Ulcerative Colitis Market to Incur Fortitude Growth During 2018-2026 by Global T …
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained
PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, an …
Targeted cancer therapy is the primary objective of extensive research related to cancer drugs. Our immune cells are programmed to attack the foreign cell on activation. PD-1 and PDL-1 are among those activation points present on the immune cells. Sometimes cancer cells also use this PD-1 and PDL-1 trigger points to avoid being attacked by the immune cells. Therefore, cancer drugs targeting these cells hold tremendous potential in the cancer

All 5 Releases


More Releases for Blepharitis

Blepharitis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Blepharitis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Blepharitis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Blepharitis Drugs with respect to individual growth
Blepharitis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results
Blepharitis is an inflammatory disorder of eyelids and can be categorized into two types; anterior and posterior blepharitis. The inflammation at the outside front of the eyelid is anterior blepharitis, whereas, inflammation at the inner eyelid is posterior blepharitis. Download the sample report @ https://www.pharmaproff.com/request-sample/1055 The major complications associated with blepharitis are the sty (acute infection of oil glands in eye), chalazion (painless lump due to inflammation of oil glands in eye),
Blepharitis Market Competitive Healthcare Assessment 2018 to 2025
Global Blepharitis Market Research Report 2018 tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Blepharitis market. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different
Blepharitis Treatment Market Opportunity Analysis, 2018-2026
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Market Display Significant Growth by 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly
Blepharitis Market Projected to be Resilient During 2017 - 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly